Gene · 3003
NIH grants2,103
NIH grants whose papers are about the gene, through NIH's grant-paper links.
1,001 to 1,020 of 2,103
Download this page as JSON| Grant | Title | GZMK papers | Newest fiscal year |
|---|---|---|---|
| P50CA062924 | SPORE in Gastrointestinal Cancers | 1 | 2022 |
| P50CA107399 | City of Hope Lymphoma SPORE | 1 | 2022 |
| R00CA230195 | Integrative framework for identifying dysregulated mechanisms in the tumor-immune microenvironment | 1 | 2022 |
| R01AG054840 | Epigenetic Mechanisms Promoting Longevity | 1 | 2022 |
| R01AI030557 | Molecular Mechanisms of Viral Entry by Membrane Fusion | 1 | 2022 |
| R01AI089956 | Congenital CMV and CNS Infection Mechanisms of Protective Immunity | 1 | 2022 |
| R01AI104739 | COMPUTATIONAL TOOLS FOR THE ANALYSIS OF HIGH-THROUGHPUT IMMUNOGLOBULIN SEQUENCING EXPERIMENTS | 1 | 2022 |
| R01AI130307 | FDC regulation of self-reactive B cells | 1 | 2022 |
| R01AI131669 | High throughput screening of orthosteric inhibitors of flavivirus protease | 1 | 2022 |
| R01AI132492 | IRF4-dependent T-cell effector programs in governing transplant outcomes | 1 | 2022 |
| R01AI134240 | Immune Correlates of Protection from TB | 1 | 2022 |
| R01AI134790 | Lung Resident, MR1-Restricted T Cells: Association with Differential Outcomes Following Exposure to M. Tuberculosis | 1 | 2022 |
| R01AI134861 | Immunometabolic and epigenetic effects of obesity on innate immune surveillance in cancer | 1 | 2022 |
| R01AI137057 | Innate-like BCR activity as a template for universal vaccination against influenza virus | 1 | 2022 |
| R01AI139536 | Neuroimmune interactions regulate development of allergic inflammation | 1 | 2022 |
| R01AI140726 | High throughput screening of the Prp8 intein splicing inhibitors for pathogenic fungi | 1 | 2022 |
| R01AI141003 | Targeting Non Viral Markers of HIV Persistence | 1 | 2022 |
| R01AR070148 | Characterizing the Takayasu arteritis genetic risk in RPS9/LILRB3 | 1 | 2022 |
| R01AR073248 | Molecular Regulation of Stem Cell Quiescence | 1 | 2022 |
| R01AR074302 | The skin microbiome in acne | 1 | 2022 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3003/grants?page=51